tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market

Elite Pharmaceuticals (ELTP) Income Statement

Compare
368 Followers

Elite Pharmaceuticals Income Statement

Last quarter (Q2 2026), Elite Pharmaceuticals's total revenue was $36.32M, an increase of 92.38% from the same quarter last year. In Q2, Elite Pharmaceuticals's net income was $13.70M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 84.04M$ 56.63M$ 34.16B$ 32.26M$ 25.38M
Gross Profit
$ 40.09M$ 26.36M$ 16.59B$ 14.80M$ 11.87M
Operating Expenses
$ 20.49M$ 15.57M$ 12.92B$ 9.72M$ 9.76M
Depreciation and Amortization
$ 2.12M$ 1.47M$ 1.33M$ 1.42M$ 1.52M
EBITDA
$ 2.84M$ 2.52M$ 6.43M$ 6.49M$ 3.63M
Operating Income
$ 19.60M$ 10.79M$ 2.03B$ 5.07M$ 2.10M
Other Income/Expenses
$ -19.65M$ -10.33M$ 309.87K$ 2.09M$ 2.04M
Pretax Income
$ -52.14K$ 463.09K$ 3.99B$ 7.16M$ 4.14M
Net Income
$ -4.31M$ 20.11M$ 4.41B$ 8.90M$ 5.09M
Per Share Metrics
Basic EPS
$ 0.00$ 0.02$ 4.35$ 0.01$ 0.01
Diluted EPS
$ 0.00$ 0.02$ 4.35$ 0.01$ 0.01
Weighted Average Shares Outstanding
1.07B 1.02B 1.01B 1.01B 943.00M
Weighted Average Shares Outstanding (Diluted)
1.07B 1.02B 1.01B 1.01B 943.00M
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History